Effect of a synthetic hexosamine derivative on mucopolysaccharide synthesis by human capsule and synovium.
D001241:Aspirin / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D002807:Chondroitin / Q000378:metabolism; D003238:Connective Tissue / Q000187:drug effects; D005944:Glucosamine / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006025:Glycosaminoglycans / Q000096:biosynthesis*; D006595:Hexosamines / Q000138:chemical synthesis / Q000494:pharmacology*; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism; D006854:Hydrocortisone / Q000494:pharmacology*; D006868:Hydrolysis; D066298:In Vitro Techniques; D007596:Joints / Q000378:metabolism*; D010003:Osteoarthritis / Q000378:metabolism; D013329:Structure-Activity Relationship; D013583:Synovial Membrane / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D006025:Glycosaminoglycans; D006595:Hexosamines; D014316:Tritium; D006820:Hyaluronic Acid; D002807:Chondroitin; D005947:Glucose; D005944:Glucosamine; D001241:Aspirin; D006854:Hydrocortisone